Related Experiment Video
Updated: Jul 8, 2026

Transcutaneous Microcirculatory Imaging in Preterm Neonates
Published on: December 31, 2015
Transient neonatal diabetes mellitus in extremely preterm infant
S Nishimaki1, T Yukawa, Y Makita
1Department of Paediatrics, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan. shigenis@med.yokohama-cu.ac.jp
Transient neonatal diabetes mellitus occurred in an extremely preterm infant. This case suggests insufficient insulin secretion began early in pregnancy and recovery time was independent of gestational maturity.
Area of Science:
- Neonatology
- Endocrinology
- Pediatric Diabetes
Background:
- Transient neonatal diabetes mellitus (TNDM) is a rare condition affecting newborns.
- Preterm infants, especially those with intrauterine growth retardation (IUGR), present unique challenges in metabolic management.
- Understanding the timing and recovery of insulin secretion in TNDM is crucial for optimal infant care.
Observation:
- A case report details an extremely preterm infant (27 weeks gestation, 718 g) with IUGR.
- The infant developed hyperglycemia on the first day of life, requiring insulin therapy.
- Insulin administration was successfully discontinued at 89 days of life, shortly before the infant's original due date.
Findings:
- This case suggests that impaired insulin secretion in TNDM can originate as early as the second trimester of pregnancy.
- The study indicates that the duration required for insulin secretion to recover in TNDM is not necessarily correlated with the infant's gestational maturity.
Implications:
- Early identification and management of hyperglycemia in preterm infants are essential.
- The findings contribute to a better understanding of the pathophysiology of TNDM in extremely preterm infants.
- This case highlights the potential for TNDM resolution irrespective of the degree of prematurity, informing clinical expectations and management strategies.
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Introduction
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Type I Diabetes II: Pathophysiology
